The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Immunocore Holdings plc ADR shares valued at $1,261,789 were sold by Berman David M on Dec 04 ’25. At $40.26 per share, Berman David M sold 31,341 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Berman David M sold 572 shares, netting a total of over 22,960 in proceeds. Following the sale of shares at $40.14 each, the insider now holds 0 shares.
Before that, Berman David M had sold 69,404 shares from its account. In a trade valued at $2,784,488, the HEAD OF R&D traded Immunocore Holdings plc ADR shares for $40.12 each. Upon closing the transaction, the insider’s holdings decreased to 69,404 shares, worth approximately $0.0.
As published in a research note from UBS on January 07, 2026, Immunocore Holdings plc ADR [IMCR] has been rated up from a Sell to a Buy and the price target has been revised to $55. Analysts at Wells Fargo started covering the stock with ‘”an Overweight”‘ outlook in a report released in late October.
Analyzing IMCR Stock Performance
On last trading session, Immunocore Holdings plc ADR [NASDAQ: IMCR] plunged -1.15% to $32.75. The stock’s lowest price that day was $32.0, but it reached a high of $33.51 in the same session. During the last five days, there has been a drop of approximately -0.91%. Over the course of the year, Immunocore Holdings plc ADR shares have jumped approximately 14.67%.
Support And Resistance Levels for Immunocore Holdings plc ADR (IMCR)
RSI (Relative Strength Index) is 39.07 on the 14-day chart, showing neutral technical sentiment.
Is Immunocore Holdings plc ADR subject to short interest?
Stocks of Immunocore Holdings plc ADR saw a sharp rise in short interest on 2025-12-31 jumping by 0.96 million shares to 9.52 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 8.56 million shares. A jump of 10.04% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 34.14 of the overall float, the days-to-cover ratio (short ratio) jumped to 34.14.
Which companies own the most shares of Immunocore Holdings plc ADR (IMCR)?
In terms of Immunocore Holdings plc ADR share price expectations, FactSet research, analysts set an average price target of 55 in the next 12 months, up nearly 66.01% from the previous closing price of $33.13. Analysts anticipate Immunocore Holdings plc ADR stock to reach 60 by 2026, with the lowest price target being 36. In spite of this, 7 analysts ranked Immunocore Holdings plc ADR stock as Buy at the end of 2026. On May 27, 2025, Deutsche Bank assigned a price target of “a Buy” to the stock and initiated coverage with a $65.
